Bioqube Ventures

Foundation date

21/01/2016

Sector

#Investor

Subsector

Bioqube ventures is a specialist life sciences investment firm that focuses on early-stage investments. We cut cost, accelerate business and bring value by linking three key components: access to capital, specialized infrastructure and expertise. Our partnership with Johnson & Johnson Innovation – JLINX, is the embodiment of our mission: a multifaceted approach that enables early-stage healthcare companies to reach their full potential in a cost effective and time efficient way.

Latest news

  • P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services

    Thursday September 5th 2024

  • reMYND appoints new CEO and Chairman to progress novel Alzheimer’s Disease program through clinical development

    Tuesday September 3rd 2024

  • Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

    Monday September 2nd 2024